Skip to content

SHIFAMED

Active
Private limited companyfounded 20241 yr activeMiddaglijnstraat 39-41, 1210 Sint-Joost-ten-Node, BelgiumKBO/BCE: BE 1015.791.423
Summary

SHIFAMED has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €25,123 and a net result of €25,123. Its solvency ranks better than 26% of 16810 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Checked score

Score 2025
Axes
Profitability100
Solvency55
Growth-
Track record67
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €2,000 at 30 days acceptable
Liquidity tight (current ratio 1.4; short-term debt: 69.9% and cash: 93.2% of total assets), and 69.9% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies more bankruptcies →
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 1 year 0 10 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
30.1%
Return on assets
30.1%
Age of the figures
9 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 1 filing
Deviation from the deadline
2025
31 d late
← before the deadline after the deadline →
Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

SHIFAMED was incorporated on 31 October 2024 as a Private limited company.1 The company has filed annual accounts once, for fiscal year 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2025

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, micro schema

Equity
€25,123
Total assets
€83,465
Net result
€25,123
Working capital
€23,522

Turnover and EBIT margin not published: the micro schema does not require them.

Balance-sheet composition
Assets €83,465
Fixed assets €1,601
Current assets €81,864
Equity and liabilities €83,465
Equity €25,123
Debt €58,342
Debt finances 69.9% of the balance-sheet total.
Key figures and ratios
2025 value
EBITDA
€25,923
Cash flow
€25,923
Current ratio
1.40
Debt to equity
2.32
ROE
100.0%
ROA
30.1%
Debt ≤ 1 year
€58,342
Staff costs
€24,044

Peer companies

Historical observation

Of the 11,280 companies that looked in July 2024 the way this one looks now, 0.7% went bankrupt within 24 months and 97% are still going.

  • Micro
  • under 2 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
0.7% went bankrupt
2.6% stopped otherwise
97% still going

For this company itself Checked computes a bankruptcy probability of 0.2% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,340 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 11,280 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 · 29 lines
Balance sheet Code2025
Assets
Total assets20/58€83,465
Fixed assets21/28€1,601
Tangible fixed assets22/27€1,601
Furniture and vehicles24€1,601
Current assets29/58€81,864
Current investments50/53€4,036
Cash at bank and in hand54/58€77,828
Equity and liabilities
Total equity and liabilities10/49€83,465
Equity10/15€25,123
Revaluation surpluses12€2,401
Profit (loss) carried forward14€25,123
Advance to shareholders on the distribution of net assets19€2,401
Amounts payable17/49€58,342
Amounts payable within one year42/48€58,342
Trade debts44€47,749
Suppliers440/4€47,749
Taxes, remuneration and social security45€9,786
Taxes450/3€1,006
Remuneration and social security454/9€8,780
Other amounts payable47/48€807
Income statement Code2025
Remuneration, social security and pensions62€24,044
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€800
Other operating charges640/8€4,801
Gross operating margin9900€54,768
Operating profit (loss)9901€25,123
Profit (loss) for the period before taxes9903€25,123
Profit (loss) for the period9904€25,123
Profit (loss) for the period to be appropriated9905€25,123
Appropriation of the result
Profit (loss) to be appropriated9906€25,123

The notes to these accounts (4 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line2025
Remuneration, social security and pensions62€24,044
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€800
Other operating charges640/8€4,801
Gross operating margin9900€54,768
Operating profit (loss)9901€25,123
Profit (loss) for the period before taxes9903€25,123
Profit (loss) for the period9904€25,123
Profit (loss) for the period to be appropriated9905€25,123
Line2025
Assets
Total assets20/58€83,465
Fixed assets21/28€1,601
Tangible fixed assets22/27€1,601
Furniture and vehicles24€1,601
Current assets29/58€81,864
Current investments50/53€4,036
Cash at bank and in hand54/58€77,828
Equity and liabilities
Total equity and liabilities10/49€83,465
Equity10/15€25,123
Revaluation surpluses12€2,401
Profit (loss) carried forward14€25,123
Advance to shareholders on the distribution of net assets19€2,401
Amounts payable17/49€58,342
Amounts payable within one year42/48€58,342
Trade debts44€47,749
Suppliers440/4€47,749
Taxes, remuneration and social security45€9,786
Taxes450/3€1,006
Remuneration and social security454/9€8,780
Other amounts payable47/48€807
Line2025
Profit (loss) for the period9904€25,123
+ Depreciation and write-downs630€800
Operating cash flow (approximation)€25,923

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

2026
31-08
NBB filing Annual accounts filed
fiscal year 2025 · micro schema · 31 days late
NBB filing
0 of 2 acts read
About the unread acts

We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
No directors read yet: 0 of 2 Gazette acts processed. See the function holders in the CBE →
Location & real-estate footprint
Registered office, Sint-Joost-ten-Node · 1 establishment unit since 2024
seat establishment The establishment unit on the map
Ground area
91 m²
Building footprint
91 m²
Volume, LiDAR
1,123 m³
Parcel 21014A0435/03F004, Brussels · tallest building 17.4 m, ±5 floors. Linked by address, not a title deed.
1 establishment unit
SHIFAMED
Middaglijnstraat 39-41, 1210 Sint-Joost-ten-NodeGeneral medical practice
since 20242.371.026.725
1 parcel
Brussels 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
21014A0435/03F004 Brussels 91 m² 1 · 91 m² 17.4 m · 5 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 9,130 companies in this sector we hold annual accounts for 6,339. 3,591 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Company details

Identification
Legal formPrivate limited company
Founded31-10-2024
Fiscal year end31-12
Activities, NACEBEL 2025
86210General medical practice
E-invoicing
Reachable via Peppol
Peppol ID 0208:1015791423
Also 9925:BE1015791423
Registered 09-02-2026

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 30 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.